PFAS Testing Lab

Navigating the Realm of PFAS Testing Labs: Understanding, Importance, and Solutions

Introduction

Per- and polyfluoroalkyl substances (PFAS) are increasingly recognized as environmental contaminants of concern, due to their pervasive presence in various ecosystems and potential health impacts. As governments, industries, and communities grapple with the challenges posed by these “forever chemicals,” the role of PFAS testing labs has become paramount. Whether you’re a municipal director responsible for clean water compliance, a design engineer developing innovative solutions, or a plant operator seeking to ensure safety, understanding the significance of PFAS testing labs is crucial in addressing one of the most pressing environmental issues of our time.

Laboratory analysis is one component of the wider PFAS Testing & Analysis discipline, which spans field sampling, screening, bench and pilot verification, and the confirmatory laboratory work described here. The distinction matters commercially: a screening result and a confirmatory result carry very different evidentiary weight, cost very different amounts, and are appropriate at very different points in an investigation. Understanding which is which prevents both over-specification and the far more expensive error of building a case on data that will not survive scrutiny.

Understanding PFAS: Sources and Risks

What Are PFAS?

PFAS are a group of synthetic chemicals characterized by a chain of carbon atoms surrounded by fluorine atoms, which grants them unique properties such as water and oil repellency. Their industrial applications range from non-stick cookware to firefighting foam and water-resistant textiles.

Sources of PFAS Contamination

According to the Environmental Protection Agency (EPA), sources of PFAS contamination are diverse and include:

  • Industrial Discharges: Manufacturing processes related to PFAS production and usage can lead to direct discharge into water bodies.
  • Aqueous Film-Forming Foam (AFFF): This firefighting foam, commonly used at airports and military bases, has been a significant source of contamination.
  • Agricultural Runoff: The application of contaminated sludge in agriculture can introduce PFAS into the food chain.

Health Risks Associated with PFAS

Emerging studies have linked PFAS exposure to various health issues including:

  • Liver damage
  • Increased cholesterol levels
  • Developmental effects in fetuses and infants
  • Immune system suppression

Regulatory Landscape

As of July 2025, the EPA has implemented stricter regulations governing PFAS. The newly standardized drinking water contaminants and necessary reporting requirements urge water suppliers to routinely monitor for PFAS, further emphasizing the critical need for reliable PFAS testing labs.

The Role of PFAS Testing Labs

Importance of Testing

PFAS testing labs serve a vital function in mitigating the risks associated with PFAS contamination. Their primary roles include:

  • Detecting PFAS Levels: Accurate quantification of PFAS levels in water, soil, and other materials.
  • Linking Contamination to Sources: Determining the sources of PFAS to enable remediation efforts and regulatory compliance.

Testing Methodologies

PFAS testing labs employ various methodologies to detect and quantify PFAS, including:

  • Liquid Chromatography-Mass Spectrometry (LC-MS): Widely utilized for its sensitivity, enabling the detection of low concentrations of PFAS.
  • Solid Phase Extraction: Used to isolate PFAS from environmental samples effectively.

In 2024, advancements in technology have led to more efficient and precise testing methods, further enhancing the reliability of PFAS testing.

Certification and Accreditation

Choosing a certified lab ensures compliance with regulatory standards. The EPA’s Methods 533 and 537.1 are commonly adopted protocols for PFAS testing, offering an added layer of reliability and credibility.

Selecting the Right PFAS Testing Lab

Key Considerations

When selecting a PFAS testing lab, municipal directors, engineers, and plant operators should consider the following:

  • Accreditation: Ensure the lab is recognized by regulatory bodies and certified for PFAS analysis.
  • Turnaround Time: Quick results are critical for timely decision-making, especially in cases of significant contamination.
  • Expertise and Support: The availability of knowledgeable staff who can explain results and provide guidance on next steps is invaluable.

Case Studies of Effective PFAS Testing

Case Study 1: City of Aventura’s Water Safety Initiative

Aventura, a city grappling with PFAS in its water supply, partnered with a certified PFAS testing lab to monitor levels and develop a robust response strategy. Regular monitoring has led to timely remediation efforts, including updated filtration systems that have decreased PFAS levels by over 90%.

Case Study 2: Aerospace Manufacturer’s Contamination Assessment

An aerospace manufacturer facing scrutiny for PFAS in wastewater utilized a PFAS testing lab to analyze runoff. Results were pivotal in altering industrial processes and greatly reducing the environmental footprint.

Solutions for PFAS Mitigation

Water Treatment Innovations

Innovations in water treatment technologies are critical in addressing PFAS contamination effectively. Techniques such as:

  • Granular Activated Carbon (GAC) Filters: Proven to reduce PFAS concentrations significantly.
  • Reverse Osmosis Systems: Effective in removing PFAS but require regular maintenance and monitoring to ensure effectiveness.

Future Directions in PFAS Remediation

With continuous advancements in science and technology, the future of PFAS remediation appears promising. Research into bio-remediation techniques and the development of PFAS-specific adsorbents aims to provide more effective solutions.

The PFAS Analytical Method Landscape

Laboratories do not offer one PFAS test. They offer a family of methods that differ in analyte coverage, matrix applicability, reporting limits, and legal defensibility, and the choice among them is the most consequential decision in a monitoring programme. The subsections below cover the principal methods and the pages that treat each in depth.

Targeted Analysis and Its Boundaries

All routine PFAS quantification is targeted: the laboratory measures a defined list of compounds against authentic standards and reports each one. Nothing outside that list is reported, whether or not it is present. Our dedicated coverage of PFAS analytical methods works through the instrumentation and sample preparation chain that underpins every method in this family — solid phase extraction, liquid chromatography separation, tandem mass spectrometry detection, and the isotope dilution or internal standard approaches used for quantification. It also addresses the practical consequences of the targeted approach: branched and linear isomer reporting conventions, the difference between a method detection limit and a reporting limit, and why two laboratories running the same nominal method can return results that differ by a factor of two at low concentrations.

EPA Method 537.1

The first widely adopted drinking water method, EPA Method 537.1 covers 18 PFAS in finished drinking water using solid phase extraction on a polystyrenedivinylbenzene cartridge followed by LC/MS/MS with surrogate-based quantification. It remains the most widely accredited method and the one most laboratories can deliver at the shortest turnaround. Its limitations are specific and worth understanding before selecting it: it does not cover several short-chain compounds now of regulatory interest, its recovery for certain replacement chemistries is poor, and its surrogate-based quantification is more susceptible to matrix effects than isotope dilution. It applies to drinking water only — using it on wastewater, leachate, or groundwater with significant matrix is outside its scope.

EPA Method 533

Developed to close the short-chain gap, EPA Method 533 covers 25 PFAS in drinking water using isotope dilution quantification, which corrects for matrix effects and extraction losses on a compound-by-compound basis rather than through a surrogate. Its analyte list emphasises shorter-chain compounds and the ether carboxylic acid replacement chemistries, and it generally achieves lower and more reproducible reporting limits than 537.1. The two methods overlap but are not interchangeable: several compounds appear on only one list, which is why compliance monitoring under the drinking water rule permits either and many programmes run both. When a monitoring plan is being written, the analyte list — not the method number — is what should be specified.

Method 1633 and Non-Potable Matrices

Neither 537.1 nor 533 applies outside drinking water, which left a substantial gap for wastewater, biosolids, soil, sediment, leachate, and tissue. EPA Method 1633 addresses it, covering 40 PFAS across those matrices with isotope dilution quantification and matrix-specific preparation procedures. Any utility characterising influent, effluent, or biosolids, and any industrial discharger operating under a pretreatment programme, will be working to 1633 rather than to the drinking water methods. Confirm that a prospective laboratory holds accreditation for 1633 in the specific matrix required, since accreditation is granted per matrix and a laboratory competent in aqueous samples may not be accredited for solids.

Screening Approaches

Confirmatory analysis is expensive and slow, which creates real demand for faster and cheaper preliminary work. PFAS screening methods occupy that space, and our dedicated page covers total oxidisable precursor screening, adsorbable and extractable organic fluorine, particle-induced gamma ray emission, combustion ion chromatography, and the emerging field-portable sensor technologies. The correct use of screening is to allocate confirmatory sampling effort intelligently — to decide which of forty wells warrants a full analysis, or to establish whether an unattributed fluorine mass exists at all. The incorrect use is to treat a screening result as a compliance datum. Screening results are generally not defensible for enforcement, permitting, or litigation, and a programme that blurs the distinction will eventually have to repeat the work.

Total Oxidizable Precursor Assay

The total oxidizable precursor assay addresses the single largest blind spot in targeted analysis. Many real samples — particularly those affected by aqueous film-forming foam or industrial discharge — carry a substantial mass of polyfluorinated precursors that no targeted method reports but that will oxidise over time in the environment into the terminal perfluoroalkyl acids that are actually regulated. The assay applies a strong chemical oxidation step under alkaline conditions to convert those precursors to measurable end products, then quantifies the difference between pre-oxidation and post-oxidation results. That difference is the precursor mass. A site whose targeted results sit comfortably below action levels but whose precursor mass is large does not have a clean result; it has a deferred one.

Branched Isomers, Reporting Conventions, and Comparability

PFOS and several other compounds occur as mixtures of linear and branched isomers, and laboratories differ in how they handle them. Some report linear and branched fractions separately, some sum them, and some quantify branched isomers against a linear standard, which introduces a systematic bias that can run to tens of percent. None of these approaches is wrong, but they are not comparable, and a dataset assembled from laboratories using different conventions cannot support a trend analysis. The convention should be fixed in the specification and stated on every report. The same applies to the treatment of results between the method detection limit and the reporting limit — whether they are reported as estimated values with a qualifier or simply as non-detects materially changes how a low-level dataset reads, and it is a question of laboratory policy rather than of method.

Comparison of PFAS Analytical Methods

The table below compares the principal methods against the criteria that decide a selection. Note that the assay discussed above is commonly referred to by its abbreviation in laboratory quotations and reports, and the practical mechanics of ordering, interpreting, and budgeting for it are covered separately under TOP assay, which addresses turnaround expectations, the oxidation conditions used by different laboratories, and how to read the pre- and post-oxidation delta.

Comparison of principal PFAS analytical and screening methods by matrix, coverage, and defensibility
Method Matrix Analytes Quantification Best Use Defensibility
EPA Method 537.1 Finished drinking water only 18 PFAS Surrogate-based Routine compliance monitoring; widest accreditation; shortest turnaround High — compliance defensible
EPA Method 533 Drinking water 25 PFAS, short-chain emphasis Isotope dilution Where short-chain and replacement chemistries matter High — compliance defensible
EPA Method 1633 Wastewater, groundwater, soil, biosolids, sediment, leachate, tissue 40 PFAS Isotope dilution Non-potable matrices; NPDES and pretreatment work; biosolids High — accreditation is per matrix
Total oxidizable precursor assay Aqueous, soil Precursor mass by difference Pre- and post-oxidation delta AFFF and industrial sites; estimating deferred liability Investigative — not a compliance datum
Total organic fluorine (AOF, EOF, CIC) Aqueous, solids Total fluorine mass Combustion ion chromatography Closing a fluorine mass balance; destruction verification Investigative
Field-portable screening Aqueous Indicative only Sensor or colourimetric Prioritising confirmatory sampling across many locations Low — screening only

Laboratory Selection and Specification Framework

Selecting a laboratory is a procurement exercise with unusually technical acceptance criteria. Working through the sequence below in order prevents the common outcome of a dataset that cost a great deal and cannot be used.

Step One: Specify the Analyte List and the Matrix, Not the Method Number

Begin by naming every compound that must be reported and every matrix that will be sampled, then let the method follow. A specification written as “PFAS analysis by EPA method” is not a specification, because the compound lists differ materially between methods and the matrix determines which are even applicable. State the required reporting limit for each compound as well, since a laboratory can satisfy a method requirement while reporting limits well above the action level the programme is measuring against.

Step Two: Verify Accreditation Per Method and Per Matrix

Accreditation under a recognised programme is granted for a specific method in a specific matrix. A laboratory accredited for 537.1 in drinking water is not thereby accredited for 1633 in biosolids, and the distinction is routinely glossed over in marketing material. Request the current scope of accreditation document rather than accepting a general claim, confirm the expiry date, and confirm that the accrediting body is recognised by the relevant state primacy agency.

Step Three: Establish the Full Quality Control Package Before Award

Agree the deliverable in advance: field, trip, and equipment blank handling, matrix spike and duplicate frequency, surrogate and internal standard recovery acceptance windows, isomer reporting convention, and whether raw data and chromatograms will be supplied. Establish how the laboratory will report a blank detection and what happens to the affected batch. These terms are cheap to negotiate before award and effectively impossible afterwards.

Step Four: Coordinate Laboratory Work With Field Sampling

Analytical quality is capped by sample quality, and PFAS sampling has an unusually long list of prohibitions and a correspondingly high failure rate. The laboratory should supply the bottles, the preservation instructions, and the field documentation, and should be consulted on the sampling plan rather than handed the results of one. Programmes extending beyond aqueous samples into soil, sediment, or biosolids should also review our coverage of PFAS field testing, which addresses solid-matrix sampling design, depth profiling, and the field decontamination procedures that determine whether a solids dataset means anything.

Field Notes

Holding the Dataset Comparable Over Time

Monitoring programmes generate value through trend, and trend requires comparability. Fix the laboratory, the method, the analyte list, and the reporting limits at the outset and hold all four constant. Changing laboratories mid-programme, or accepting an upgrade from 537.1 to 533, introduces a step change in the data that cannot be reliably distinguished from a real change in the water. Where a change is unavoidable, run a parallel period on both configurations so the offset can be characterised rather than guessed at.

Pro Tip

Ask for the reporting limit per compound in writing before you award, and check it against the action level you actually have to defend. A laboratory quoting an attractive price frequently achieves it with reporting limits above the regulatory threshold, which produces a page of non-detects that prove nothing. A non-detect at a reporting limit of 20 nanograms per litre tells you nothing at all about compliance with a 4 nanogram per litre limit.

Common Specification Mistakes

Five recur. Specifying a method number instead of an analyte list and a matrix. Accepting a general accreditation claim without the scope document. Omitting the reporting limit requirement, then discovering the results cannot address the question. Treating a screening result as a compliance datum, which usually surfaces only when the result is challenged. And sampling before the laboratory has been engaged, so that bottles, preservation, and blank protocol are all improvised in the field. None of these is expensive to avoid; all of them are expensive to correct, because the remedy is always to resample.

Common Mistake

Storing only the summed PFAS value from historical rounds. Compound distribution — particularly the long-chain to short-chain ratio — is what predicts carbon and resin bed life and drives the entire treatment technology decision. A utility that retained only a summed figure cannot reconstruct that ratio when the treatment decision arrives, and will pay to resample water it already analysed. Retain the full analyte-level dataset from every round, including compounds that are not currently regulated.

Interpreting Results and Blanks

Two interpretation errors dominate. The first is treating a detection in a field or equipment blank as a nuisance rather than as an invalidation of that batch — ambient PFAS contamination in field materials readily exceeds the concentrations being measured, so a positive blank means the associated results cannot be relied on. The second is comparing results across rounds without checking that reporting limits were identical; an apparent improvement is frequently a change in reporting limit rather than a change in the water. Read the case narrative and the quality control summary, not only the results table.

Data Quality and Standards

Accreditation and Quality Systems

  • NELAP / TNI accreditation: the principal recognised programme in the United States, granted per method and per matrix; request the current scope document.
  • ISO/IEC 17025: the international competence standard for testing laboratories, frequently held alongside NELAP.
  • DoD/DOE QSM: required for Department of Defense work and widely used as a benchmark for the most rigorous quality systems.
  • State primacy agency recognition: confirm the accrediting body is accepted by the state that will receive the data.

Regulatory Context

Compliance monitoring for PFAS in public drinking water arises under the Safe Drinking Water Act through the National Primary Drinking Water Regulation finalised for PFAS in April 2024, which established enforceable maximum contaminant levels for PFOA and PFOS together with limits and a Hazard Index approach for several additional compounds. Elements of that rule, including the compliance schedule and the treatment of the compounds beyond PFOA and PFOS, have been subject to subsequent agency reconsideration and litigation, so the operative monitoring requirement and schedule should be confirmed against the current Federal Register text and the state primacy agency. Approved analytical methods for that monitoring are EPA Methods 537.1 and 533. Non-potable monitoring arises under the Clean Water Act through NPDES permits and pretreatment programmes, using EPA Method 1633. The CERCLA hazardous substance designation for PFOA and PFOS creates separate reporting obligations for which data defensibility standards are correspondingly higher. Many states have adopted standards more stringent than the federal values or require additional analytes, so the state requirement should be checked in every case.

Laboratory Selection Checklist

  1. Complete analyte list specified, with a required reporting limit stated for each compound.
  2. Every matrix to be sampled identified, with the applicable method named for each.
  3. Current scope of accreditation document obtained, checked per method and per matrix, and confirmed unexpired.
  4. Accrediting body confirmed as recognised by the receiving state agency.
  5. Quality control package agreed: blank types and frequency, spikes, duplicates, recovery windows.
  6. Isomer reporting convention and treatment of branched species agreed in writing.
  7. Blank-detection protocol defined, including what invalidates a batch.
  8. Turnaround time committed, with the expedited option and its cost identified in advance.
  9. Bottles, preservation, shipping, and field documentation supplied by the laboratory.
  10. Laboratory consulted on the sampling plan before the first round is collected.
  11. Data deliverable format specified, including whether raw data and chromatograms are included.
  12. Analyte-level historical data retention arranged, not only summed values.

Frequently Asked Questions

What is the difference between EPA Method 537.1 and EPA Method 533?

Both are drinking water methods approved for compliance monitoring, but they differ in coverage and quantification. Method 537.1 covers 18 PFAS using surrogate-based quantification; Method 533 covers 25 with an emphasis on shorter-chain compounds and replacement chemistries, and uses isotope dilution, which corrects for matrix effects compound by compound and generally yields lower, more reproducible reporting limits. The analyte lists overlap but are not identical, which is why many programmes run both rather than choosing between them.

Why can a drinking water method not be used on wastewater or soil?

Methods 537.1 and 533 were validated for finished drinking water, a comparatively clean matrix. Wastewater, leachate, soil, sediment, and biosolids introduce interferences, competing organics, and extraction difficulties that those methods were never designed to handle, so results from them in those matrices are not defensible. EPA Method 1633 exists specifically to cover the non-potable matrices, and laboratory accreditation for it is granted per matrix rather than in general.

How much does PFAS laboratory analysis cost and how long does it take?

Costs vary widely by method, matrix, analyte count, and turnaround. Confirmatory drinking water analysis is typically the least expensive per sample; non-potable matrices under Method 1633 cost substantially more because of the preparation burden; precursor and total fluorine work adds further cost. Standard turnaround is commonly two to four weeks, with expedited options available at a premium. Because laboratory capacity for PFAS has been tight, commit turnaround contractually rather than assuming it, particularly around regulatory deadlines.

Is a screening result good enough for compliance?

Generally no. Screening approaches are designed to be fast and inexpensive, and they trade defensibility for that speed. They are valuable for prioritising where confirmatory samples should be taken and for establishing whether unattributed fluorine mass exists, but they are not appropriate for enforcement, permitting, or litigation. Any result that will be defended should come from an accredited laboratory running an approved method for the matrix in question.

What does the total oxidizable precursor assay add over standard analysis?

It quantifies what targeted analysis cannot see. Polyfluorinated precursors present in many samples are not reported by any targeted method, but they transform in the environment into the regulated terminal compounds. The assay oxidises them and reports the difference before and after, which is the precursor mass. It is most valuable at sites with AFFF or industrial history, where a large precursor mass means today’s comfortable result understates tomorrow’s liability.

Why do two laboratories report different results for the same sample?

Several legitimate reasons, and one avoidable one. Legitimate differences arise from different methods with different analyte lists, different reporting limits, different isomer reporting conventions, and different quantification approaches. Near the reporting limit, variability of a factor of two between laboratories is not unusual. The avoidable cause is sample-side: field contamination, inconsistent preservation, or holding time exceedance. Split-sample comparison between laboratories is a reasonable diagnostic, but it should be designed with both laboratories informed rather than run as an audit.

How many samples does a monitoring programme actually need?

That depends on what the programme has to demonstrate. Establishing whether a problem exists can be done with a small number of well-placed samples supported by screening. Establishing a defensible baseline for a compliance or liability position requires enough rounds to characterise seasonal and operational variability, which generally means quarterly sampling across at least a full year before any trend claim is credible. Source investigation is different again and is driven by hydrogeology rather than by a schedule. Design the programme around the question being answered rather than around a default sampling frequency, and budget for the resamples that blank failures and holding time exceedances will inevitably require.

Should sampling be done in-house or by the laboratory?

Either can work, but the decision should be deliberate. Laboratory-performed sampling costs more per round and transfers responsibility for field protocol and blank handling to a party that understands the failure modes, which is worth a great deal on a first round or a legally sensitive investigation. In-house sampling is substantially cheaper and appropriate for routine monitoring once staff have been trained on the prohibited-materials list and the blank regime and the protocol has been documented. The worst arrangement is in-house sampling without training, which produces a dataset that looks complete and fails when examined.

Key Takeaways

  • Specify the analyte list and matrix, not the method number — compound lists differ materially between methods, and the matrix determines which methods even apply.
  • Accreditation is per method and per matrix — request the scope document rather than accepting a general claim, and confirm the accrediting body is recognised by the receiving state.
  • Reporting limits decide whether data is usable — a non-detect above the action level answers nothing, so state the required limit per compound before award.
  • Screening and confirmation serve different purposes — screening allocates confirmatory effort intelligently; it is not a compliance datum and will not survive challenge.
  • Targeted analysis has a precursor blind spot — at AFFF and industrial sites, the oxidisable precursor mass is the difference between a clean result and a deferred one.
  • Retain analyte-level data, never just the sum — the long-chain to short-chain ratio drives the eventual treatment decision and cannot be reconstructed from a summed figure.
  • Hold the configuration constant — changing laboratory, method, or reporting limit mid-programme creates a step change in the data that is indistinguishable from a real change in the water.

Conclusion

In a world that increasingly recognizes the risks posed by PFAS, the role of PFAS testing labs cannot be overstated. They serve as the frontline defense against contamination, enabling effective monitoring and remediation strategies. As you navigate the complexities of PFAS regulations and seek to ensure safe water for your community or facility, partnering with a reliable PFAS testing lab is not just a recommendation; it is an essential prerequisite for responsible environmental stewardship.

By equipping yourself with knowledge and working with accredited labs, stakeholders can effectively address PFAS-related challenges and contribute to a cleaner, safer, and healthier environment for all. As we look toward future innovations and regulatory standards, understanding the importance of PFAS testing will remain a cornerstone of effective environmental management.